In COVID-19 clinical update #52, Daniel Griffin reviews differences in attack rates between children and adults, J&J vaccine phase III data, G6PD deficiency and vaccines, NIH halts convalescent plasma trial, dexamethasone in hospitalized patients, data on tocilizumab, and long COVID in children.

Hosts: Daniel Griffin and Vincent Racaniello

Subscribe (free): iTunes, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

• SARS-CoV-2 attack rates in children and adults (Clin Inf Dis)
• Documents for J&J COVID-19 vaccine review (FDA)
• Convalescent plasma and clinical outcomes (JAMA)
• NIH halts convalescent plasma trial (NIH)
• Dexamethasone in hospitalized COVID-19 patients (NEJM)
• Tocilizumab in hospitalized COVID-19 patients (NEJM)
• Update on long COVID prevalence (UK ONS)
• Letters read on TWiV 727
• Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]